TI
AGN

tru Independence’s Allergan plc AGN Stock Holding History

tru Independence’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,656
Closed -$470 – 951
2020
Q1 		$470 Hold
2,656
– – 0.08% 149
2019
Q4 		$470K Buy
+2,656
New +$479K 0.07% 170

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

tru Independence's AGN Position: Q2 2020 in Review

tru Independence sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,656 shares — an estimated $470 sold.

tru Independence first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $470K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • tru Independence reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • tru Independence sold 2,656 Allergan plc shares in Q2 2020, an estimated $470.
  • tru Independence first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • tru Independence's Allergan plc position peaked at $470K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on tru Independence's 13F filing for Q2 2020, filed 19 Aug 2020.